8-K
filed June 12, 2026, 4:19 PM ET
ticker WHWK
CIK 0001422142
other
confidence high
sentiment neutral
materiality 0.15
Whitehawk Therapeutics shareholders elect three Class III directors at annual meeting
Whitehawk Therapeutics, Inc.
- Behzad Aghazadeh, Richard Maroun, and Emma Reeve elected as Class III directors with 26.7M, 27.7M, and 27.7M votes for, respectively.
- Advisory say-on-pay passed with 22.9M for, 6.0M against, 3.6M abstain.
- Ratification of BDO USA as auditor for FY 2026 passed with 34.8M for, 1.1M against, 4.4M abstain.
- Approximately 82% of voting power (40.4M shares) present, constituting a quorum.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Whitehawk Therapeutics, Inc. shareholders approved Election of three Class III directors at the 2026-06-11 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
Behzad Aghazadeh, Ph.D. 26,666,124 5,867,225 7,841,674 Richard Maroun 27,701,332 4,832,017 7,841,674 Emma Reeve 27,704,564 4,828,785 7,841,674
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Whitehawk Therapeutics, Inc. shareholders approved Ratification of BDO USA, P.C. as independent registered public accounting firm at the 2026-06-11 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstentions 34,795,850 1,148,282 4,430,891
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Whitehawk Therapeutics, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-11 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
Proposal 2: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the “Executive Compensation” section of the Proxy Statement. For Against Abstentions Broker Non-Votes 22,896,061 6,013,600 3,623,688 7,841,674
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.